The Efficacy of L-Carnitine in the Management of Acute Carbon Monoxide Poisoning
Carbon Monoxide Poisoning
About this trial
This is an interventional treatment trial for Carbon Monoxide Poisoning focused on measuring Carbon Monoxide Poisoning, Cardiotoxicity, Troponin, L-Carnitine, Outcome
Eligibility Criteria
Inclusion Criteria: The current clinical trials will include patients with moderate and severe acute carbon monoxide poisoning according to Poisoning Severity Score. Exclusion Criteria: When the diagnosis of acute carbon monoxide poisoning is unconfirmed. Patients with advanced cardiac and neurological diseases.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Conventional Group
L-Carnitine Group
This group will comprise 36 patients who will receive conventional supportive treatment for the management of acute CO poisoning that include the following: Airway: maintaining clear patent airways. Breathing: High-flow normobaric oxygen (NBO) Hyperbaric oxygen (HBO) (if indicated). Mechanical ventilation ( if required). Circulation: intravenous fluids, and treatment of arrhythmias according to ECG abnormalities.
The 36 patients will receive conventional supportive care as in the conventional group in addition to IV L-carnitine.